HHealth Read More BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer TrialsOctober 2, 2026 BriaCell Therapeutics’ (TSX:BCT,NASDAQ:BCTX) Phase 3 Bria-ABC study has been included in a roundup of breast cancer clinical trials…